|
 | 国联医药消费混合-A(015032)基金投资组合(持股) 年份： | | 截止日期 | 股票代码 | 股票名称 | 数量(万股) | 持有市值(万元) | 占基金资产净值比例(%) | | 2026-06-30 | 600276 | 恒瑞医药 | 9.28 | 483.04 | 23.72% | | 2026-06-30 | 688266 | 泽璟制药 | 3.78 | 441.38 | 21.67% | | 2026-06-30 | 688428 | 诺诚健华 | 14.22 | 404.81 | 19.88% | | 2026-06-30 | 688192 | 迪哲医药 | 10.03 | 400.38 | 19.66% | | 2026-06-30 | 688382 | 益方生物 | 18.29 | 329.20 | 16.16% | | 2026-06-30 | 688331 | 荣昌生物 | 2.44 | 317.18 | 15.57% | | 2026-06-30 | 002755 | 奥赛康 | 22.37 | 304.68 | 14.96% | | 2026-06-30 | 688180 | 君实生物 | 8.75 | 295.91 | 14.53% | | 2026-06-30 | 002714 | 牧原股份 | 5.09 | 178.10 | 8.75% | | 2026-06-30 | 688062 | 迈威生物 | 6.19 | 174.86 | 8.59% | | 2026-06-30 | 002311 | 海大集团 | 3.64 | 162.38 | 7.97% | | 2026-06-30 | 002100 | 天康生物 | 19.09 | 120.46 | 5.91% | | 2026-06-30 | 603477 | 巨星农牧 | 7.86 | 116.33 | 5.71% | | 2026-06-30 | 300558 | 贝达药业 | 1.63 | 106.06 | 5.21% | | 2026-06-30 | 002840 | 华统股份 | 11.49 | 83.76 | 4.11% | | 2026-06-30 | 603259 | 药明康德 | 0.53 | 65.99 | 3.24% | | 2026-06-30 | 600519 | 贵州茅台 | 0.05 | 59.27 | 2.91% | | 2026-06-30 | 603127 | 昭衍新药 | 1.48 | 56.57 | 2.78% | | 2026-06-30 | 300498 | 温氏股份 | 3.48 | 42.87 | 2.11% | | 2026-06-30 | 688710 | 益诺思 | 0.63 | 42.33 | 2.08% | | 2026-06-30 | 002821 | 凯莱英 | 0.17 | 27.54 | 1.35% | | 2026-06-30 | 688506 | 百利天恒 | 0.03 | 9.85 | 0.48% | | 2026-06-30 | 688271 | 联影医疗 | 0.02 | 2.02 | 0.10% | | 2026-06-30 | 688131 | 皓元医药 | 0.02 | 1.89 | 0.09% | | 2026-06-30 | 688336 | 三生国健 | 0.03 | 1.54 | 0.08% | | 2026-06-30 | 301393 | 昊帆生物 | 0.02 | 1.30 | 0.06% | | 2026-06-30 | 300347 | 泰格医药 | 0.02 | 0.96 | 0.05% | | 2026-06-30 | 688351 | 微电生理 | 0.02 | 0.45 | 0.02% | | 2026-06-30 | 300633 | 开立医疗 | 0.02 | 0.37 | 0.02% | | 2026-06-30 | 688553 | 汇宇制药 | 0.03 | 0.31 | 0.02% | |
|